Literature DB >> 6514295

Factors affecting visual loss in benign intracranial hypertension.

J C Orcutt, N G Page, M D Sanders.   

Abstract

Visual function and optic disc appearances were studied in 68 patients conforming to established criteria of benign intracranial hypertension (BIH). The clinical, radiological, and laboratory findings of those patients whose visual field or acuity deteriorated were compared with those who did not deteriorate over an average follow-up of 4.1 years. Definite loss of visual function occurred in 49% of eyes and was severe in 6%. Patients with high grade or atrophic papilledema, or peripapillary subretinal hemorrhage, were significantly more likely to have had deterioration of visual function. Transient obscurations of vision and the presence of optico-ciliary shunts were associated with severe visual loss. Anemia, older age, and high myopia were other risk factors for visual loss. Chronic papilledema may cause progressive visual loss and, for this reason, BIH is not a benign condition; fundal changes and visual function should be carefully monitored.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514295     DOI: 10.1016/s0161-6420(84)34149-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  32 in total

1.  Doxycycline induced intracranial hypertension.

Authors:  J Lochhead; J S Elston
Journal:  BMJ       Date:  2003-03-22

2.  Racial differences in idiopathic intracranial hypertension.

Authors:  B B Bruce; P Preechawat; N J Newman; M J Lynn; V Biousse
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

3.  Vision loss in pseudotumor cerebri.

Authors:  J C Orcutt
Journal:  West J Med       Date:  1988-06

4.  Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome.

Authors:  M L R Monteiro; C L Afonso
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

Review 5.  Optical coherence tomography imaging of the optic nerve head pre optic and post optic nerve sheath fenestration.

Authors:  Haziq Raees Chowdhury; Saul Rajak; Dominic Heath; Paul Brittain
Journal:  BMJ Case Rep       Date:  2015-07-06

6.  Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response.

Authors:  Jason C Park; Heather E Moss; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2017-11-14       Impact factor: 2.379

7.  Idiopathic intracranial hypertension: relation between obesity and visual outcomes.

Authors:  Aimee J Szewka; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2013-03       Impact factor: 3.042

Review 8.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

9.  Papilloedema and visual failure in a patient with nocturnal hypoventilation.

Authors:  P J Kirkpatrick; T Meyer; N Sarkies; J D Pickard; H Whitehouse; P Smielewski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

10.  Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure.

Authors:  J F Acheson; W T Green; M D Sanders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.